MET

NYSE

METLIFE INC

Financials, Life & Health Insurance

$97.77

close 7 Aug 2026

+29.84%

52-week change

$62.35B

market cap

$67.33

$100.93

52-week range

Expected price

$66.05 – $80.73

Current price

$97.77

Signal

Could be overvalued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)18.69x

P/S (TTM)0.79x

P/B2.27x

EV/EBITDA (TTM)—

FCF yield (TTM)—

PEG (TTM, GAAP)—

Context

P/E, own 5-year average15.75x

P/E, sector median16.04x*

Price at 5-year median P/E$71.81*

Indicated dividend yield2.43%

Forward — analyst consensus

Forward P/E (FY2026)9.98x*

Forward P/E (FY2027)8.97x

Forward PEG0.89*

Consensus EPS FY2026 (18 analysts)$9.80

EPS growth (FY2026→FY2027)11.24%

Revenue growth (FY2026)1.73%

Street view

Price target (mean)$100.44*

Target upside2.73%

Ratings (buy / hold / sell)12 / 5 / 1

FY2026 EPS revisions, 30d (up / down)5 / 9

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 30 Jun 2026, filed 6 Aug 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

No free cash flow history is available for this company.

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$97.77

Cash & equivalents$19.30B

Total debt$746.00M

Shares outstanding637.75M

Result

DCF price per share—

Current price$97.77

Margin of safety—

PV of years 1–10—

PV of terminal value—

Equity value—

Market-implied growth—

Projected FCF, years 1–10

Hover for PV and growth

Complete the assumptions to draw the projection.

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	—	—	—	—	—	—	—	—	—	—	—
PV	—	—	—	—	—	—	—	—	—	—	—

period to 30 Jun 2026, filed 6 Aug 2026, close 7 Aug 2026